Professional
Added to YB: 2025-05-07
Pitch date: 2025-03-31
BSX [neutral]
Boston Scientific Corporation
-7.79%
current return
Author Info
No bio for this author
Company Info
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide.
Market Cap
$144.6B
Pitch Price
$100.40
Price Target
N/A
Dividend
N/A
EV/EBITDA
30.09
P/E
52.15
EV/Sales
8.04
Sector
Health Care Equipment and Supplies
Category
growth
Baron Health Care Fund Portfolio Holding: Boston Scientific Corporation
BSX (holding update): Medical device leader positioned well in electrophysiology & structural heart, with 9% end market growth. PFA technology has advantage over temperature-based methods for heart tissue treatment, using electricity to selectively treat aberrant tissue. Cost discipline + 50+ bps annual op margin expansion driving double-digit EPS growth.
Read full article (1 min)